The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis

Lipopolysaccharide enhanced renal vascular response to endothelin-1 through ETAoverexpression in portal hypertensive rats

(2014) Chiao-Lin Chuang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

P2X7 Receptor Modulates Inflammatory and Functional Pulmonary Changes Induced by Silica

(2014) Leonardo C. Monção-Ribeiro et al.   PLoS One

P2X7receptor activation contributes to an initial upstream mechanism of lipopolysaccharide-induced vascular dysfunction

(2013) Chin-Wei Chiao et al.   CLINICAL SCIENCE

Decoding cell death signals in liver inflammation

(2013) Catherine Brenner et al.   JOURNAL OF HEPATOLOGY

Expression of P2X7 Receptor Increases In Vivo Tumor Growth

(2012) E. Adinolfi et al.   CANCER RESEARCH

Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats

(2012) Hui-Chun Huang et al.   HEPATOLOGY

Functional aspects on the pathophysiology of portal hypertension in cirrhosis

(2012) Juan-Carlos García-Pagán et al.   JOURNAL OF HEPATOLOGY

The role of P2X7 purinergic receptors in inflammatory and nociceptive changes accompanying cyclophosphamide-induced haemorrhagic cystitis in mice

(2011) JP Martins et al.   BRITISH JOURNAL OF PHARMACOLOGY

Extracellular ATP Is a Danger Signal Activating P2X7Receptor in Lung Inflammation and Fibrosis

(2010) Nicolas Riteau et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The management of portal hypertension: Rational basis, available treatments and future options

(2008) Jaime Bosch et al.   JOURNAL OF HEPATOLOGY

P2X7 Receptor Activation Amplifies Lipopolysaccharide-Induced Vascular Hyporeactivity via Interleukin-1  Release

(2008) C.-W. Chiao et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS